Navidea Biopharmaceutical... (NAVB)
0.00
-0.00 (-100.00%)
At close: Feb 27, 2025, 3:00 PM
0.00
11.11%
Pre-market: Sep 03, 2024, 09:30 AM EDT
Diagnostics Segment Revenue
History
Quarter | Value | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 610 | 610 | n/a |
Sep 30, 2022 | 0 | n/a | n/a |
Dec 31, 2021 | 0 | -30.32K | -100.00% |
Dec 31, 2020 | 30.32K | -124.56K | -80.42% |
Sep 30, 2020 | 154.89K | n/a | n/a |
Jun 30, 2020 | n/a | n/a | n/a |
Mar 31, 2020 | 82.14K | 42.99K | +109.84% |
Mar 31, 2019 | 39.14K | -4.97K | -11.27% |
Dec 31, 2018 | 44.11K | -35.88K | -44.86% |
Dec 31, 2017 | 80K | 66.81K | +506.50% |
Sep 30, 2017 | 13.19K | -80.03K | -85.85% |
Jun 30, 2017 | 93.22K | 84.56K | +975.50% |
Mar 31, 2017 | 8.67K | -12.02K | -58.11% |
Sep 30, 2016 | 20.69K | -82.21K | -79.89% |
Jun 30, 2016 | 102.9K | n/a | n/a |
Mar 31, 2016 | n/a | n/a | n/a |
Dec 31, 2015 | n/a | n/a | n/a |
Sep 30, 2015 | n/a | n/a | n/a |
Jun 30, 2015 | 0 | n/a | n/a |
Mar 31, 2015 | 0 | n/a | n/a |